Discontinued — last reported Q4 '23
Geographic · Property, plant and equipment
Developed Europe — Property, plant and equipment
Pfizer Developed Europe — Property, plant and equipment increased by 15.4% to $6.22B in Q4 2023 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2016
Last reportedQ4 2023Feb 22, 2024
Rolls up toPP&E (Net)
How to read this metric
An increase suggests capital investment in regional infrastructure, while a decrease may indicate asset divestiture or depreciation outpacing new investment.
Detailed definition
This metric represents the net book value of tangible long-term assets located within the Developed Europe geographic se...
Peer comparison
Comparable to regional property, plant, and equipment (PP&E) disclosures found in the geographic segment reporting of other multinational pharmaceutical companies.
Metric ID:
pfe_segment_developed_europe_property_plant_and_equipmentHistorical Data
3 periods
| Q4 '21 | Q4 '22 | Q4 '23 | |
|---|---|---|---|
| Value | $5.09B | $5.39B | $6.22B |
| QoQ Change | — | +5.8% | +15.4% |
| YoY Change | — | +5.8% | +15.4% |
Range$5.09B – $6.22B
Avg YoY Growth+10.6%
Median YoY Growth+10.6%
Current Streak2+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Pfizer's developed europe — property, plant and equipment?
- Pfizer (PFE) reported developed europe — property, plant and equipment of $6.22B in Q4 2023.
- What does developed europe — property, plant and equipment mean?
- The total value of physical assets like factories and labs owned by the company in Developed Europe.